Squalamine

Squalamine

Squalamine is a steroid derived from the dogfish shark (Squalus acanthias). It was first isolated and identified in 1993 by Dr. Michael Zasloff and his team. Squalamine is a natural product that exhibits broad-spectrum antimicrobial and antiangiogenic properties.

Chemistry

Squalamine is a polyamine-steroid conjugate, consisting of a 7,24-dihydroxylated 24-sulfated cholic acid, linked to a spermidine at the C-3 position. The molecule is amphipathic, meaning it has both hydrophilic and hydrophobic properties, which allows it to interact with cell membranes.

Biological Activity

Squalamine has been found to exhibit a broad range of biological activities. It has potent antimicrobial activity against a variety of bacteria, fungi, and protozoa. It also exhibits potent antiangiogenic activity, which has led to its investigation as a potential treatment for cancer and age-related macular degeneration (AMD).

Antimicrobial Activity

Squalamine interacts with the cell membrane of microorganisms, disrupting their normal function and leading to cell death. It has been found to be effective against a wide range of organisms, including Gram-positive bacteria, Gram-negative bacteria, and fungi.

Antiangiogenic Activity

Squalamine inhibits the growth of new blood vessels, a process known as angiogenesis. This property has led to its investigation as a potential treatment for diseases characterized by excessive angiogenesis, such as cancer and age-related macular degeneration (AMD).

Clinical Use

Squalamine has been investigated in clinical trials for the treatment of cancer and age-related macular degeneration (AMD). While results have been promising, further research is needed to fully understand its potential therapeutic applications.

See Also

• Shark
• Steroid
• Antimicrobial
• Antiangiogenic
• Clinical trial

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

This marine biology related article is a stub. You can help WikiMD by expanding it.